This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Political Activist Filmmaker Kevin Booth Retained By Cannabis Science To Film Specialty Documentary

Stocks in this article: CBIS

Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is thrilled to announce that the company has retained filmmaker Kevin Booth to collaborate on a documentary researching cannabis as a medicine and the truth behind the science of marijuana.

Many people know Kevin Booth’s work with the late comedian, Bill Hicks. Kevin produced most of Bill’s CDs and videos that led to the comedian’s own HBO specials and multiple appearances on David Letterman. The story of Kevin’s seventeen-year friendship and working partnership with Bill Hicks was recently explored in a feature length BBC documentary that just ended a year long run of festivals and theatrical screenings. After Bill’s death from pancreatic cancer in 1994, Kevin’s filmmaking took on a political turn and he produced documentaries with talk show host Alex Jones about the incident in Waco, Texas, the American two-party political system, and 9/11. In 2005, Kevin traveled to the UK in order to promote his book titled “Agent of Evolution” about his friendship with Bill Hicks - published by Harper Collins.

Several of Kevin’s family members died as a result of alcohol, tobacco, and pharmaceutical use. In 2003 Kevin began investigating the drug war in the United States and produced the documentary “American Drug War: The Last White Hope.” In his investigations, he discovered the United States government considers marijuana more dangerous than crack cocaine or crystal meth. Kevin sought to separate fact from fiction by traveling across the United States, documenting the “fallout” from the War on Drugs and seeking possible solutions and alternatives that have worked elsewhere. Kevin has toured the country, showing his film and lecturing at universities in hope of sparking a meaningful debate. “American Drug War” won best feature documentary at several film festivals from coast to coast and aired continuously on the Showtime network between 2008-2010. During this same time the film was also broadcasted on major networks in Canada, Australia, Poland, Lebanon and South Africa. Kevin recently returned from filming in Juarez Mexico for the follow up to “American Drug War" and is aiming for the sequel’s release later this year.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,422.75 +35.54 0.20%
S&P 500 2,026.68 -2.87 -0.14%
NASDAQ 4,686.5640 +5.0670 0.11%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs